Word

ONCO/RESOLVE

Status

Dead

Status Code

606

Status Date

Monday, June 17, 2019

Serial Number

87619641

Mark Type

4000

Filing Date

Friday, September 22, 2017

Published for Opposition

Tuesday, March 20, 2018

Abandoned Date

Monday, June 17, 2019

Trademark Owner History

Pillar Biosciences, Inc. - Owner At Publication

Classifications

1 Reagents and reagent kits comprising nucleic acids, naturally occurring and modified nucleotides, enzymes, buffers, and adhesive reagent labels, all for the purpose of preparing, detecting, sequencing, and analyzing nucleic acids and other biological molecules, samples of biological molecules, genes, genomes, nucleotide sequence variants and modifications, regulations, transcriptions, and expressions, with the aforementioned reagents and reagent kits being in the fields of scientific research, clinical research, and scientific diagnostics research; Biological and biochemical reagents used for selectively amplifying nucleic acid fragments for scientific research, clinical research, and scientific diagnostics research

5 Reagents and reagent kits comprising nucleic acids, naturally occurring and modified nucleotides, enzymes, buffers, and adhesive reagent labels, all for the purpose of preparing, detecting, sequencing, and analyzing nucleic acids and other biological molecules, samples of biological molecules, genes, genomes, nucleotide sequence variants and modifications, regulations, transcriptions, and expressions, with the aforementioned reagents and reagent kits being for medical diagnostic purposes; Biological and biochemical reagents used for selectively amplifying nucleic acid fragments, with the aforementioned reagents being used for medical diagnostic purposes; Biological and biochemical kits comprised of diagnostic preparations for medical purposes, namely, for the diagnosis and treatment of cancer

9 Computer software for the collection, management, and analysis of data for use in the fields of scientific research, clinical research, scientific diagnostics, and medical diagnostics; computer software for analyzing biological samples; computer software for analyzing biological samples for medical purposes, namely, for the diagnosis and treatment of cancer; computer software for use with reagents and reagent kits, all for use in detecting, sequencing, and analyzing nucleic acids and other biological molecules, samples of biological molecules, genes, genomes, nucleotide sequence variants and modifications, all in the fields of scientific research, clinical research, scientific diagnostics research, and medical diagnostics; computer software for bioinformatics and gene expression microarray image analysis, namely, gene expression quantification, gene image processing, and gene information processing

42 Software as a service (SaaS), namely, hosting non-downloadable computer software for use by others for collecting, managing, and analyzing data in the fields of scientific research, clinical research, scientific diagnostics, and medical diagnostics; software as a service (SaaS), namely, hosting non-downloadable computer software for use by others for analyzing biological samples; software as a service (SaaS), namely, hosting non-downloadable computer software for use by others for analyzing biological samples for medical purposes, namely, for the diagnosis and treatment of cancer; software as a service (SaaS), namely, hosting non-downloadable computer software for use by others with reagents and reagent kits, all for use in detecting, sequencing, and analyzing nucleic acids and other biological molecules, samples of biological molecules, genes, genomes, nucleotide sequence variants and modifications, all in the fields of scientific research, clinical research, scientific diagnostics research, and medical diagnostics; software as a service (Saas), namely, hosting non-downloadable computer software for use by others for bioinformatics and gene expression microarray image analysis, namely, gene expression quantification, gene image processing, and gene information processing; scientific research, namely, collection, management, and analysis of data in the fields of scientific research, clinical research and scientific diagnostics; providing biological sample testing services for others in the fields of scientific research, clinical research and scientific diagnostics; providing reagent sample testing and diagnostic services for others, namely, detecting, sequencing, and analyzing nucleic acids and other biological molecules, samples of biological molecules, genes, genomes, nucleotide sequence variants and modifications, all in the fields of scientific research, clinical research, and scientific diagnostics research; genetic testing for scientific research purposes in the nature of providing bioinformatics and gene expression microarray image analysis services for others, namely, performing gene expression quantification, gene image processing, and gene information processing for others; medical diagnostic research, namely, collection, management, and analysis of data in the field of medical diagnostics

44 Providing biological sample testing services for others in the field of medical diagnostics; providing biological sample testing services for others for medical purposes, namely, for the diagnosis and treatment of cancer; medical diagnostic testing in the nature of providing reagent sample testing and diagnostic services for others, namely, detecting, sequencing, and analyzing nucleic acids and other biological molecules, samples of biological molecules, genes, genomes, nucleotide sequence variants and modifications, all in the field of medical diagnostics

ON CO/RESOLVE

Trademark Events

Jun 17, 2019

Abandonment Notice E-Mailed - No Use Statement Filed

Jun 17, 2019

Abandonment - No Use Statement Filed

Nov 17, 2018

Notice Of Approval Of Extension Request E-Mailed

Nov 15, 2018

Extension 1 Granted

Nov 15, 2018

Extension 1 Filed

Nov 15, 2018

Teas Extension Received

May 15, 2018

Noa E-Mailed - Sou Required From Applicant

Mar 20, 2018

Official Gazette Publication Confirmation E-Mailed

Mar 20, 2018

Published For Opposition

Feb 28, 2018

Notification Of Notice Of Publication E-Mailed

Feb 8, 2018

Approved For Pub - Principal Register

Jan 25, 2018

Teas/Email Correspondence Entered

Jan 24, 2018

Correspondence Received In Law Office

Jan 24, 2018

Teas Response To Office Action Received

Jan 4, 2018

Notification Of Non-Final Action E-Mailed

Jan 4, 2018

Non-Final Action E-Mailed

Jan 4, 2018

Non-Final Action Written

Dec 28, 2017

Assigned To Examiner

Sep 28, 2017

New Application Office Supplied Data Entered In Tram

Sep 26, 2017

New Application Entered In Tram